SMS Pharmaceuticals Limited (BOM:532815)
249.95
-3.95 (-1.56%)
At close: Jun 5, 2025
SMS Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 691.36 | 498.26 | -70.59 | 622.2 | 625.27 | Upgrade
|
Depreciation & Amortization | 343.37 | 314.67 | 320.72 | 320.93 | 221.89 | Upgrade
|
Other Amortization | 1.47 | 2.05 | 2.2 | 2.51 | 1.55 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.21 | -0.37 | 0.54 | -0.02 | -0.02 | Upgrade
|
Loss (Gain) From Sale of Investments | 9.75 | 2.25 | 2.01 | 1.56 | - | Upgrade
|
Provision & Write-off of Bad Debts | - | - | - | - | 0.78 | Upgrade
|
Other Operating Activities | 202.13 | 229.88 | 282.52 | 87.18 | 178.85 | Upgrade
|
Change in Accounts Receivable | 330 | -878.47 | -998.27 | 571.61 | -569.88 | Upgrade
|
Change in Inventory | -510.31 | -101.98 | 275.98 | -1,133 | -85.87 | Upgrade
|
Change in Accounts Payable | -374.06 | 438.68 | 424.37 | 74.18 | 209.46 | Upgrade
|
Change in Income Taxes | 15.34 | 43.06 | 32.91 | -14.58 | 1.13 | Upgrade
|
Change in Other Net Operating Assets | 108.26 | -46.77 | -47.89 | -81.85 | 321.37 | Upgrade
|
Operating Cash Flow | 817.09 | 501.25 | 224.5 | 450.6 | 904.53 | Upgrade
|
Operating Cash Flow Growth | 63.01% | 123.27% | -50.18% | -50.19% | 127.77% | Upgrade
|
Capital Expenditures | -1,234 | -521.6 | -299.21 | -272.47 | -1,517 | Upgrade
|
Sale of Property, Plant & Equipment | 0.56 | 0.88 | 2.63 | 0.17 | 1.33 | Upgrade
|
Investment in Securities | - | -0.07 | -1.68 | - | - | Upgrade
|
Other Investing Activities | -1.05 | 0.07 | 0.69 | 0.77 | 0.24 | Upgrade
|
Investing Cash Flow | -1,234 | -520.72 | -297.56 | -271.53 | -1,516 | Upgrade
|
Short-Term Debt Issued | 108.03 | 202.07 | 258.77 | 8.89 | 117.26 | Upgrade
|
Long-Term Debt Issued | 637.24 | 450.86 | 94.14 | 451.9 | 1,057 | Upgrade
|
Total Debt Issued | 745.27 | 652.93 | 352.91 | 460.79 | 1,175 | Upgrade
|
Short-Term Debt Repaid | - | - | - | -38.35 | -20.22 | Upgrade
|
Long-Term Debt Repaid | -447.99 | -388.01 | -437.93 | -337.45 | -172.7 | Upgrade
|
Total Debt Repaid | -447.99 | -388.01 | -437.93 | -375.8 | -192.92 | Upgrade
|
Net Debt Issued (Repaid) | 297.28 | 264.92 | -85.02 | 84.99 | 981.62 | Upgrade
|
Common Dividends Paid | -33.86 | -25.4 | -25.4 | -25.4 | - | Upgrade
|
Other Financing Activities | 207.37 | 67.26 | -209.28 | -177.06 | -61.44 | Upgrade
|
Financing Cash Flow | 470.79 | 306.79 | -319.69 | -117.47 | 920.18 | Upgrade
|
Net Cash Flow | 53.6 | 287.32 | -392.75 | 61.6 | 308.79 | Upgrade
|
Free Cash Flow | -416.71 | -20.35 | -74.71 | 178.12 | -612.96 | Upgrade
|
Free Cash Flow Margin | -5.28% | -0.29% | -1.43% | 3.43% | -10.88% | Upgrade
|
Free Cash Flow Per Share | -4.92 | -0.24 | -0.88 | 2.10 | -7.24 | Upgrade
|
Cash Interest Paid | - | 217.52 | 209.28 | 177.06 | 61.44 | Upgrade
|
Cash Income Tax Paid | - | 154 | 46 | 149.2 | 160.46 | Upgrade
|
Levered Free Cash Flow | -663.45 | -249.36 | -316 | -224.79 | -1,030 | Upgrade
|
Unlevered Free Cash Flow | -549.04 | -109.55 | -186.46 | -113.22 | -966.97 | Upgrade
|
Change in Net Working Capital | 351.6 | 440.67 | 350.37 | 681.48 | 293.93 | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.